Ge Lan, the first sister of the public offering, was hit by rumors.
On February 10, a rumor pointing to Glenn spread in the market.
it is rumored that recently, large institutions, including large venture capital, wealth management and fof special accounts, redeemed the fund shares of Ge Lan, the star fund manager of China Europe, and was redeemed by nearly 40 billion yuan. The reason is that she arranged many new energy varieties such as Contemporary Amperex Technology Co.Limited(300750) at a high level, and several industry wide funds she managed bought 70% of new energy.
In this regard, the relevant person in charge of China Europe Fund told the 21st Century Business Herald reporter that , the online rumors of "large redemption" are untrue, and please don't believe the rumors.
Related topics rushed to microblog hot search:
In response to the rumour that the fund was redeemed for 40 billion yuan in large quantities, the netizens were not forgetting to make complaints about the truth.
Regarding the fact that Ge Lan was picked up by fans for hot search due to the collapse of "Yao Ming Department", Dan bin, chairman of Shenzhen Oriental harbor investment and well-known private placement, said on personal social media that everyone has their own ideas and judgments in investment, and it is easy to blame others, but it is not easy to stick to what they think is right. It is easy in good times and difficult in bad times, And it's very difficult. That's why it's hard to keep stocks.
heavy warehouse stocks fell sharply again
On February 10, Wuxi Apptec Co.Ltd(603259) the first heavyweight stock of Gelan managed fund fell by 7.41% again due to the pessimistic expectation of foreign policies.
In the three trading days since February 8, Wuxi Apptec Co.Ltd(603259) has fallen by nearly 20%, halving from the highest point in July last year.
Wuxi Apptec Co.Ltd(603259) has always been a heavy stock of fund products managed by Ge Lan. According to the data, as of December 31, 2021, the four funds managed by Ge Lan held a total of Wuxi Apptec Co.Ltd(603259) 81.3116 million shares, that is, if the position has not changed in recent two months, the floating loss of Ge Lan's four products reached 840 million on February 8 alone.
Recently, the "Yaoming series" fell sharply across the board, closing at 94.06 yuan / share on Wuxi Apptec Co.Ltd(603259) on February 8.
Subsequently, Wuxi Apptec Co.Ltd(603259) issued a Clarification Announcement, saying that the production and operation of the company and its subsidiaries were normal.
But the decline continues. On February 10, CXO concept stocks fell sharply, Wuxi Apptec Co.Ltd(603259) , Asymchem Laboratories (Tianjin) Co.Ltd(002821) , Hangzhou Tigermed Consulting Co.Ltd(300347) and so on.
Some industry analysts said that today's collective weakness may be related to the current large-scale redemption of fund shares by institutions.
In this regard, the China Europe Fund responded that the online rumors of "large redemption" are untrue. Please don't believe the rumors.
the first sister of the fund questioned
Glenn, who has just been promoted to the top 100 billion, fell into a vortex of public opinion.
On January 22, China Europe Fund disclosed the 2021 fourth quarter report of some of its funds. By the end of 2021, the scale of the five funds managed by star fund manager Glenn had officially exceeded 100 billion yuan, reaching 110.339 billion yuan. It is the largest fund manager in charge of active equity funds. Compared with 97.001 billion yuan at the end of the third quarter of 2021, it increased by 13.338 billion yuan.
At present, Glenn manages five funds, namely China Europe medical and health, China Europe Mingrui new starting point, China Europe alpha, China Europe medical innovation and China Europe research selected funds.
In June 2021, Glenn's representative work, the net value of China EU medical and health, reached the peak, achieved a good result of 350% growth in four years, and was sought after by a large number of investors.
however, from the second half of 2021, with the adjustment of the pharmaceutical industry, the fund performed poorly, and the net value retreated by more than 30%.
Among them, the largest central European medical and health care has fallen below last year's low. This means that a large number of new funders held by the fund last year have fallen into losses so far.
As a result, investors have been wildly angered. In this regard, some insiders said that under the situation that the pharmaceutical industry as a whole is callback, the fund industry managed by Glenn cannot be alone. It is also because of the pharmaceutical theme fund, the heavy positions are relatively concentrated, and the stock price changes of heavy positions also have a great impact on the overall fund.
As for the operation ideas, Glenn said in the four seasons that it has maintained the operation of high positions in general, and has made a key layout in the long-term promising innovative drug industry chain, medical services, leading enterprises of high-quality generic drugs and other directions.
From the perspective of future configuration direction, Glenn pointed out that the innovative drug industry chain is still her most promising direction for a long time. From the top-level design of policies at the national level to the innovation accumulation of Chinese enterprises in recent years, China's innovative pharmaceutical industry chain has been maintained in a high-profile state for a long time.
